Good Health Can’t Wait.

More documents

Recommendations

Info

Good Health Can’t Wait. Dr. Reddy’s Laboratories Limited EXHIBIT 8 CEO AND CFO CERTIFICATE TO THE BOARD PURSUANT TO CLAUSE 49 OF THE LISTING AGREEMENT OF THE SEBI We, G V Prasad, Co-Chairman, Managing Director and Chief Executive Officer, and Saumen Chakraborty, President and Chief Financial Officer, to the best of our knowledge and belief, certify that: A. We have reviewed the financial statements including cash flow statement (standalone and consolidated) for the financial year ended 31 March 2015 and that these statements: i. do not contain any materially untrue statement or omit any material fact or contain statements that might be misleading; ii. together present a true and fair view of the Company’s affairs and are in compliance with existing accounting standards, applicable laws and regulations. B. There are no transactions entered into by the Company during the year, which are fraudulent, illegal or violate the Company’s Code of Business Conduct and Ethics. C. We accept the responsibility for establishing and maintaining internal controls for financial reporting and that we have evaluated the effectiveness of internal control systems of the Company pertaining to financial reporting and have disclosed to the auditors and the Audit Committee, deficiencies in the design or operation of such internal controls, if any, of which we are aware and the steps we have taken or propose to take to address these deficiencies. D. We have disclosed, wherever applicable, to the auditors and the Audit Committee: i. that there were no deficiencies in the design or operations of internal controls that could adversely affect the Company’s ability to record, process, summarize and report financial data including any corrective actions; ii. that there are no material weaknesses in the internal controls over financial reporting; iii. that there are no significant changes in internal control over financial reporting during the year; iv. all significant changes in the accounting policies during the year, if any, and the same have been disclosed in the notes to the financial statements; and v. that there are no instances of significant fraud of which we have become aware of and involvement therein of the management or an employee having a significant role in the Company’s internal control system over financial reporting. G V Prasad Co-Chairman, Managing Director & Chief Executive Officer Saumen Chakraborty President & Chief Financial Officer Place Hyderabad Date 12 May 2015 AUDITORS’ CERTIFICATE ON CORPORATE GOVERNANCE To the members of Dr. Reddy’s Laboratories Limited We have examined the compliance of conditions of Corporate Governance by Dr. Reddy’s Laboratories Limited (“the Company”), for the year ended on 31 March 2015, as stipulated in Clause 49 of the Listing Agreement of the Company with the stock exchanges in India and amendments thereof. The compliance of conditions of Corporate Governance is the responsibility of the management. Our examination was limited to procedures and implementation thereof, adopted by the Company for ensuring the compliance of the conditions of the Corporate Governance. It is neither an audit nor an expression of opinion on the financial statements of the Company. In our opinion and to the best of our information and according to the explanations given to us, we certify that the Company has complied with the conditions of Corporate Governance as stipulated in the above mentioned Listing Agreement. We further state that such compliance is neither an assurance as to the future viability of the Company nor the efficiency or effectiveness with which the management has conducted the affairs of the Company. for B S R & Co. LLP Chartered Accountants Firm Registration No.: 101248W/W-100022 Supreet Sachdev Partner Membership No.: 205385 Place Hyderabad Date 12 May 2015 70
Statutory Reports • Additional Shareholders’ Information Annual Report 2014 - 15 Additional Shareholders’ Information CONTACT INFORMATION REGISTERED AND CORPORATE OFFICE Dr. Reddy’s Laboratories Limited 8-2-337, Road No. 3, Banjara Hills Hyderabad 500 034 Telangana, India Tel: +91-40-4900 2900 Fax: +91-40-4900 2999 Website: www.drreddys.com CIN: L85195TG1984PLC004507 E-mail ID: shares@drreddys.com MEDIA Calvin Printer Corporate Communications Tel: +91-40-4900 2121 Fax: +91-40-4900 2999 E-mail ID: calvinprinter@drreddys.com INDIAN RETAIL INVESTORS Sandeep Poddar Company Secretary Tel: +91-40-4900 2222 Fax: +91-40-4900 2999 E-mail ID: shares@drreddys.com ANNUAL GENERAL MEETING Date Friday, 31 July 2015 Time 9.30 AM Venue Grand Ball Room, Hotel Taj Krishna, Road No.1, Banjara Hills, Hyderabad 500 034 Last date for receipt of proxy forms: Wednesday, 29 July 2015 before 9.30 AM. DIVIDEND The Board of Directors of the Company has proposed a dividend of ` 20 per share on equity shares of ` 5 each. The dividend, if declared by the shareholders at the 31st Annual General Meeting scheduled to be held on 31 July 2015, will be paid on or after 7 August 2015. BOOK CLOSURE DATE The dates of book closure are from Tuesday, 14 July 2015 to Friday, 17 July 2015 (both days inclusive) for the purpose of payment of dividend. FY2015 represents fiscal year 2014-15, from 1 April 2014 to 31 March 2015. Analogously for FY2014 and previously such labeled years. REPRESENTING OFFICERS Correspondence to the following officers may be addressed at the registered and corporate office of the Company. COMPLIANCE OFFICER UNDER LISTING AGREEMENT Sandeep Poddar Company Secretary Tel: +91-40-4900 2222 Fax: +91-40-4900 2999 E-mail ID: spoddar@drreddys.com ADR INVESTORS/INSTITUTIONAL INVESTORS/FINANCIAL ANALYSTS Kedar Upadhye Investor Relations Tel: +91-40-6683 4297 Fax: +91-40-2373 1955 E-mail ID: kedaru@drreddys.com INTERNATIONAL SECURITIES IDENTIFICATION NUMBER (ISIN) ISIN is a unique identification number of traded scrip. This number has to be quoted in each transaction relating to the dematerialised securities of the Company. The ISIN number of the equity shares of the Company is INE089A01023. CUSIP NUMBER FOR ADRs The Committee on Uniform Security Identification Procedures (CUSIP) of the American Bankers Association has developed a numbering system for securities. A CUSIP number uniquely identifies a security and its issuer and this is recognized globally by organizations adhering to standards issued by the International Securities Organization. 71
Page 1 and 2:
ANNUAL REPORT 2014-15 Good Health C
Page 3 and 4:
Our Brand We are in the business of
Page 5 and 6:
Corporate Overview Annual Report 20
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22: Corporate Overview Annual Report 20
Page 29 and 30: Statutory Reports • Business Resp
Page 43 and 44: Statutory Reports • Management Di
Page 57 and 58: Statutory Reports • Corporate Gov
Page 71: Statutory Reports • Corporate Gov
Page 75 and 76: Statutory Reports • Additional Sh
Page 87 and 88: Statutory Reports • Board’s Rep
Page 111 and 112: Standalone Financial Statements Ann
Page 123 and 124:
Standalone Financial Statements Ann
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Consolidated Financial Statements A
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Notice Annual Report 2014 - 15 NOTI
Page 229 and 230:
E-Voting Annual Report 2014 - 15 IN
Page 231:
Dr. Reddy’s Laboratories Limited
Page 235 and 236:
The future belongs, not to those wh
show all

Good Health Can’t Wait.

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?